These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 21917979)

  • 21. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
    Haese N; Brocato RL; Henderson T; Nilles ML; Kwilas SA; Josleyn MD; Hammerbeck CD; Schiltz J; Royals M; Ballantyne J; Hooper JW; Bradley DS
    PLoS Negl Trop Dis; 2015; 9(6):e0003803. PubMed ID: 26046641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString.
    Brocato RL; Altamura LA; Carey BD; Perley CC; Blancett CD; Minogue TD; Hooper JW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009592. PubMed ID: 34339406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-
    Vial C; Whitaker A; Wilhelm J; Ovalle J; Perez R; Valdivieso F; Ferres M; Martinez-Valdebenito C; Eisenhauer P; Mertz GJ; Hooper JW; Botten JW; Vial PA
    Front Cell Infect Microbiol; 2020; 10():444. PubMed ID: 33042854
    [No Abstract]   [Full Text] [Related]  

  • 25. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
    de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
    J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.
    Schountz T; Quackenbush S; Rovnak J; Haddock E; Black WC; Feldmann H; Prescott J
    J Virol; 2014 Aug; 88(15):8319-31. PubMed ID: 24829335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique Interferon Pathway Regulation by the Andes Virus Nucleocapsid Protein Is Conferred by Phosphorylation of Serine 386.
    Simons MJ; Gorbunova EE; Mackow ER
    J Virol; 2019 May; 93(10):. PubMed ID: 30867297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.
    Wahl-Jensen V; Chapman J; Asher L; Fisher R; Zimmerman M; Larsen T; Hooper JW
    J Virol; 2007 Jul; 81(14):7449-62. PubMed ID: 17475651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.
    Choi JA; Wu K; Kim GN; Saeedian N; Seon SH; Park G; Jung DI; Jeong HW; Kim NH; Seo SH; Lee S; Song M; Kang CY
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
    Espeseth AS; Yuan M; Citron M; Reiserova L; Morrow G; Wilson A; Horton M; Rukhman M; Kinek K; Hou F; Li SL; Li F; Choi Y; Heidecker G; Luo B; Wu G; Zhang L; Strable E; DeStefano J; Secore S; Mukhopadhyay TK; Richardson DD; Sayeed E; Welch LS; Bett AJ; Feinberg MB; Gupta SB; Cooper CL; Parks CL
    EBioMedicine; 2022 Aug; 82():104203. PubMed ID: 35915046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
    J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of recombinant VSV-Ebola virus vaccine vector in pigs.
    de Wit E; Marzi A; Bushmaker T; Brining D; Scott D; Richt JA; Geisbert TW; Feldmann H
    Emerg Infect Dis; 2015 Apr; 21(4):702-4. PubMed ID: 25811738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability.
    Pepini T; Gorbunova EE; Gavrilovskaya IN; Mackow JE; Mackow ER
    J Virol; 2010 Nov; 84(22):11929-36. PubMed ID: 20844033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Andes virus entry and neutralization using a pseudovirion system.
    Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A
    J Virol Methods; 2010 Feb; 163(2):416-23. PubMed ID: 19903496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo.
    Garrido JL; Prescott J; Calvo M; Bravo F; Alvarez R; Salas A; Riquelme R; Rioseco ML; Williamson BN; Haddock E; Feldmann H; Barria MI
    Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.
    Vera-Otarola J; Solis L; Lowy F; Olguín V; Angulo J; Pino K; Tischler ND; Otth C; Padula P; López-Lastra M
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First human isolate of Hantavirus (Andes virus) in the Americas.
    Galeno H; Mora J; Villagra E; Fernandez J; Hernandez J; Mertz GJ; Ramirez E
    Emerg Infect Dis; 2002 Jul; 8(7):657-61. PubMed ID: 12095430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.
    Warner BM; Sloan A; Deschambault Y; Dowhanik S; Tierney K; Audet J; Liu G; Stein DR; Lung O; Buchanan C; Sroga P; Griffin BD; Siragam V; Frost KL; Booth S; Banadyga L; Saturday G; Scott D; Kobasa D; Safronetz D
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33627395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
    Hooper JW; Brocato RL; Kwilas SA; Hammerbeck CD; Josleyn MD; Royals M; Ballantyne J; Wu H; Jiao JA; Matsushita H; Sullivan EJ
    Sci Transl Med; 2014 Nov; 6(264):264ra162. PubMed ID: 25429055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.